Literature DB >> 7794057

Effect of long term intramuscular gold therapy on the seroprevalence of Helicobacter pylori in patients with early rheumatoid arthritis.

L Paimela, M Leirisalo-Repo, T U Kosunen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7794057      PMCID： PMC1005613          DOI： 10.1136/ard.54.5.437-a

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  8 in total

1.  1958 Revision of diagnostic criteria for rheumatoid arthritis.

Authors:  M W ROPES; G A BENNETT; S COBB; R JACOX; R A JESSAR
Journal:  Bull Rheum Dis       Date:  1958-12

2.  Campylobacter pyloridis-associated chronic active antral gastritis. A prospective study of its prevalence and the effects of antibacterial and antiulcer treatment.

Authors:  E A Rauws; W Langenberg; H J Houthoff; H C Zanen; G N Tytgat
Journal:  Gastroenterology       Date:  1988-01       Impact factor: 22.682

3.  No effect of intramuscular gold therapy on serological parameters of Helicobacter pylori infection in patients with rheumatoid arthritis: a 12 month prospective study.

Authors:  S ten Wolde; M Janssen; W van Duijn; C B Lamers; J Hermans; B A Dijkmans
Journal:  Ann Rheum Dis       Date:  1994-06       Impact factor: 19.103

4.  Helicobacter pylori seroprevalence in patients with rheumatoid arthritis: effect of nonsteroidal anti-inflammatory drugs and gold compounds.

Authors:  G P Gubbins; T T Schubert; F Attanasio; M Lubetsky; G I Perez-Perez; M J Blaser
Journal:  Am J Med       Date:  1992-10       Impact factor: 4.965

5.  Diagnostic value of decreasing IgG, IgA, and IgM antibody titres after eradication of Helicobacter pylori.

Authors:  T U Kosunen; K Seppälä; S Sarna; P Sipponen
Journal:  Lancet       Date:  1992-04-11       Impact factor: 79.321

6.  Age-dependent increase of Campylobacter pylori antibodies in blood donors.

Authors:  T U Kosunen; J Höök; H I Rautelin; G Myllylä
Journal:  Scand J Gastroenterol       Date:  1989-01       Impact factor: 2.423

7.  Helicobacter pylori and peptic ulcers in rheumatoid arthritis patients receiving gold, sulfasalazine, and nonsteroidal anti-inflammatory drugs.

Authors:  A S Taha; R D Sturrock; R I Russell
Journal:  Am J Gastroenterol       Date:  1992-12       Impact factor: 10.864

8.  Decreased level of antibodies against Helicobacter pylori in patients with rheumatoid arthritis receiving intramuscular gold.

Authors:  M Janssen; B A Dijkmans; J P Vandenbroucke; W van Duijn; A S Peña; C B Lamers
Journal:  Ann Rheum Dis       Date:  1992-09       Impact factor: 19.103
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.